Ernexa Announces 1-for-15 Reverse Stock Split Effective June 12 To Regain Nasdaq Compliance
10/6 20:26
(RTTNews) - Ernexa Therapeutics (ERNA), a biotech firm focused on cell therapies for cancer and autoimmune diseases, will implement a 1-for-15 reverse stock split of its common shares, effective June 12, 2025....